Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
|Articles|June 15, 2005
CMS issues ruling on IOLs for presbyopia
The Centers for Medicare &Medicaid Services (CMS) rulingon May 3 sets forth CMS policy concerning the requirements fordetermining payment for insertion of presbyopia-correcting IOLs following cataract surgery under thefollowing sections of the SocialSecurity Act (the Act):
Advertisement
The Centers for Medicare &Medicaid Services (CMS) rulingon May 3 sets forth CMS policy concerning the requirements fordetermining payment for insertion of presbyopia-correcting IOLs following cataract surgery under thefollowing sections of the SocialSecurity Act (the Act):
Source: Centers for Medicare & Medicaid Services/
Advertisement
Related to this article
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Ophthalmology is projected to face one of the steepest physician shortages of any subspecialty by 2038.
Two investigational pipeline therapies take aim at the root causes of dry eye disease
Dry eye care pivots to root-cause diagnosis and personalized biologics/devices,
Cataract surgery becomes refractive: learn how IOL choices and preop counseling across distance, intermediate and near turn 20/20 into 20/happy.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.
June brings FDA clearance for Lumvoa, key retina and glaucoma trials, device deals, and hard truths on AI performance in eye care.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA approves phentolamine ophthalmic solution 0.75% (Ryzumvi) for presbyopia
2
FDA approves subcutaneous Enspryng for TED
3
Uveitis: a practical guide for ophthalmologists and optometrists
4
Varicose veins linked to central serous chorioretinopathy in large cohort study
5